US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vyome Holdings, Inc.

8.04

+0.12001.52%

Post-market: 8.040.00000.00%19:49 EDT

Volume:35.92K

Turnover:286.64K

Market Cap:5.41M

PE:-0.02

High:8.21

Open:8.00

Low:7.81

Close:7.92

52wk High:1,212.99

52wk Low:7.48

Shares:673.30K

Float Shares:669.07K

Volume Ratio:0.68

T/O Rate:5.37%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-384.8847

EPS(LYR):-1,382.9220

ROE:--

ROA:-43.02%

PB:-1.08

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Vyome Holdings appoints Richard Fahrner as CTO

BRIEF-Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies

Vyome Holdings Inc. Strengthens Leadership Team with New CTO and SVP Appointments Amid Pivotal Trial Preparations

Vyome Holdings Strengthens Leadership Team With Industry Veterans as It Plans Pivotal Trial Studies

THOMSON REUTERS

Vyome Holdings Inc: Vt-1953 Continues to Significantly Improve Primary Endpoint

THOMSON REUTERS

Vyome Holdings Inc: Positive Interim Data From Phase 2 Study of Vt-1953 in Malignant Fungating Wounds

THOMSON REUTERS

Vyome Holdings Announces Promising Interim Results from Phase 2 Study of VT-1953 for Malignant Fungating Wounds, Highlights $1B Market Opportunity

Vyome Holdings Inc. Completes Merger and Begins Trading on Nasdaq Under New Ticker "HIND

Vyome Holdings Inc. and Embryyo Sign MoU to Enter AI-Enabled Medical Device Market

Vyome Signs Mou With Embryyo, India’s Leading Medical Device Innovation Studio

THOMSON REUTERS

BRIEF-Vyome Enters Amendment No. 1 To Equity Distribution Agreement

Vyome Holdings Inc - Amendment Increases Offering to $12 Mln - SEC Filing

THOMSON REUTERS

Vyome Holdings Inc. Announces Change in Independent Auditor, Appoints Kreit & Chiu CPA LLP

Vyome Holdings Inc. Completes Merger with Vyome Therapeutics, Renames Itself Following the Transaction

Top Midday Decliners

MT Newswires Live

Vyome to Conduct Strategic Review of Livechain; Shares Down Pre-Bell

MT Newswires Live

Vyome Announces Strategic Review of Livechain (Otcid: Lich)

THOMSON REUTERS

Vyome Holdings Inc - Board to Review Options for Livechain, Including Sale or Merger

THOMSON REUTERS

ReShape Lifesciences Inc. Merges with Vyome, Now Trading as Vyome Holdings, Inc

Vyome Closes Merger Transaction, Will Trade on Nasdaq as Hind Tomorrow

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HIND/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HIND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIND\",,,,,undefined,":{"symbol":"HIND","market":"US","secType":"STK","nameCN":"Vyome Holdings, Inc.","latestPrice":8.04,"timestamp":1757534400000,"preClose":7.92,"halted":0,"volume":35918,"hourTrading":{"tag":"盘后","latestPrice":8.04,"preClose":8.04,"latestTime":"19:49 EDT","volume":20,"amount":160.03,"timestamp":1757548186004},"delay":0,"floatShares":669071,"shares":673300,"eps":-384.88467,"marketStatus":"Closed","change":0.12,"latestTime":"09-10 16:00:00 EDT","open":8,"high":8.2129,"low":7.813,"amount":286638.893742,"amplitude":0.050492,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-384.88467,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1757577600000},"marketStatusCode":5,"adr":0,"listingDate":1475726400000,"exchange":"NASDAQ","adjPreClose":7.92,"preHourTrading":{"tag":"盘前","latestPrice":8.01,"preClose":7.92,"latestTime":"09:07 EDT","volume":1,"amount":8.01,"timestamp":1757509626974},"postHourTrading":{"tag":"盘后","latestPrice":8.04,"preClose":8.04,"latestTime":"19:49 EDT","volume":20,"amount":160.03,"timestamp":1757548186004},"volumeRatio":0.680673},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIND\",,,,,undefined,":{"symbol":"HIND","floatShares":669071,"roa":"-43.02%","roe":"--","lyrEps":-1382.92198,"volumeRatio":0.680673,"shares":673300,"dividePrice":0,"high":8.2129,"amplitude":0.050492,"preClose":7.92,"low":7.813,"week52Low":7.48,"pbRate":"-1.08","psRate":"13.72","week52High":1212.99,"institutionHeld":0,"latestPrice":8.04,"eps":-384.88467,"divideRate":0,"volume":35918,"delay":0,"ttmEps":-384.88467,"open":8,"prevYearClose":446,"prevWeekClose":7.95,"prevMonthClose":9.2,"prevQuarterClose":9.76,"fiveDayClose":8.555,"twentyDayClose":8.12,"sixtyDayClose":10.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-15","symbol":"HIND","defaultRemindTime":1755264600000,"type":"split","dateTimestamp":1755230400000,"forFactor":4,"toFactor":1,"ratio":4},{"market":"US","date":"2025-08-14","symbol":"HIND","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-2.25},{"market":"US","date":"2025-05-21","symbol":"HIND","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747800000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-05-09","symbol":"HIND","defaultRemindTime":1746797400000,"type":"split","dateTimestamp":1746763200000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2025-04-04","symbol":"HIND","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743739200000,"reportTimeType":"post","actualEps":-1.89}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIND\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HIND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HIND","date":"2025-09-09","current":-0.002143,"percent":0.916667,"low":-13.499407,"twenty":-13.051381,"median":-10.790143,"eighty":-9.478905,"high":-0.002106,"avg":-9.769195,"sd":4.381227,"marketCap":3122},"quantilePoints":[{"date":"2025-08-22","current":-12.854344,"twenty":-12.392244,"median":-11.699095,"eighty":-11.005946,"marketCap":20748595},{"date":"2025-08-29","current":-11.259279,"twenty":-13.22027,"median":-12.854344,"eighty":-11.500884,"marketCap":18173952},{"date":"2025-09-05","current":-9.124707,"twenty":-13.182739,"median":-11.259279,"eighty":-10.03366,"marketCap":14728473},{"date":"2025-09-09","current":-0.002143,"twenty":-13.051381,"median":-10.790143,"eighty":-9.478905,"marketCap":3122}],"updateTime":1757549805054},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIND\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566618373","title":"Vyome Holdings appoints Richard Fahrner as CTO","url":"https://stock-news.laohu8.com/highlight/detail?id=2566618373","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566618373?lang=en_us&edition=fundamental","pubTime":"2025-09-09 21:11","pubTimestamp":1757423479,"startTime":"0","endTime":"0","summary":"Vyome Holdings (HIND) announced the appointment of Richard Fahrner as CTO and Tamara Agajanov as senior VP – clinical development. Fahrner brings t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vyome-holdings-appoints-richard-fahrner-as-cto-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vyome-holdings-appoints-richard-fahrner-as-cto-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1066051498.USD","HIND","LU1066051811.HKD","LU1066051225.USD","BK4082","BK4160","LU1066053197.SGD","CTO"],"gpt_icon":0},{"id":"2566469756","title":"BRIEF-Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2566469756","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566469756?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:35","pubTimestamp":1757421304,"startTime":"0","endTime":"0","summary":"BRIEF-Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial StudiesSept 9 (Reuters) - Vyome Holdings Inc HIND.O:VYOME HOLDINGS STRENGTHENS LEADERSHIP TEAM WITH IN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUABBFBWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2566364697","title":"Vyome Holdings Inc. Strengthens Leadership Team with New CTO and SVP Appointments Amid Pivotal Trial Preparations","url":"https://stock-news.laohu8.com/highlight/detail?id=2566364697","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566364697?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:30","pubTimestamp":1757421048,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc. has announced the appointment of Dr. Richard Fahrner as Chief Technology Officer and Dr. Tamara Agajanov as Senior Vice President of Clinical Development. Dr. Fahrner brings over 25 years of drug development experience, while Dr. Agajanov has nearly 30 years of expertise in clinical operations, particularly in oncology, immunology, and inflammation. These appointments come as Vyome plans pivotal trial studies, including a Phase 2 study in malignant fungating wounds, with results expected by October 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire  on September 09, 2025, and is solely responsible for the informat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDLbmNPdR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2566669785","title":"Vyome Holdings Strengthens Leadership Team With Industry Veterans as It Plans Pivotal Trial Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2566669785","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566669785?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:30","pubTimestamp":1757421002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nTUABBFBWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2564374739","title":"Vyome Holdings Inc: Vt-1953 Continues to Significantly Improve Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2564374739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564374739?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:31","pubTimestamp":1756989085,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nFWN3UR09R:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2564337475","title":"Vyome Holdings Inc: Positive Interim Data From Phase 2 Study of Vt-1953 in Malignant Fungating Wounds","url":"https://stock-news.laohu8.com/highlight/detail?id=2564337475","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564337475?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:31","pubTimestamp":1756989085,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nFWN3UR09R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2564374798","title":"Vyome Holdings Announces Promising Interim Results from Phase 2 Study of VT-1953 for Malignant Fungating Wounds, Highlights $1B Market Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2564374798","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564374798?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:31","pubTimestamp":1756989072,"startTime":"0","endTime":"0","summary":"Vyome Holdings Announces Promising Interim Results from Phase 2 Study of VT-1953 for Malignant Fungating Wounds, Highlights $1B Market Opportunity. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire  on September 04, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL82JHNs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4082"],"gpt_icon":0},{"id":"2564745804","title":"Vyome Holdings Inc. Completes Merger and Begins Trading on Nasdaq Under New Ticker \"HIND","url":"https://stock-news.laohu8.com/highlight/detail?id=2564745804","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564745804?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:06","pubTimestamp":1756814797,"startTime":"0","endTime":"0","summary":"Vyome Holdings, Inc. has undergone a significant transition following the resignation of ReShape's Board of Directors and management team. The new Board and management team from Vyome have been installed, and the company has been successfully listed on the Nasdaq exchange. As part of this merger, ReShape has been renamed Vyome Holdings, Inc.  and will now focus on advancing its immuno-inflammatory assets and exploring opportunities within the US-Indian innovation corridor. Additionally, the company announced the issuance of 376,256 common shares to consultants, advisors, and for terminating a share subscription agreement. Three put/call option agreements have also been established, including one involving the exchange of shares between Indian stockholders and VHI common stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for information","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDLBK1tr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2561461366","title":"Vyome Holdings Inc. and Embryyo Sign MoU to Enter AI-Enabled Medical Device Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2561461366","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561461366?lang=en_us&edition=fundamental","pubTime":"2025-08-21 19:01","pubTimestamp":1755774069,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc., a clinical-stage healthcare holding company, announced a Memorandum of Understanding  with Embryyo Technologies, a leading medical device innovation studio in India. This partnership aims to tap into the global AI-enabled medical device market by combining Vyome's industry expertise and resources with Embryyo's technological capabilities. The collaboration will focus on developing and commercializing transformative medical devices across areas such as interventional oncology, surgery, wearables, and drug delivery. Vyome and Embryyo plan to host a global innovation forum for AI-enabled medical devices, targeting opportunities along the US-India corridor. This initiative is part of Vyome's strategic focus on pharma, AI, and medical devices to enhance healthcare standards worldwide.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL2Hkxsq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND"],"gpt_icon":0},{"id":"2561461507","title":"Vyome Signs Mou With Embryyo, India’s Leading Medical Device Innovation Studio","url":"https://stock-news.laohu8.com/highlight/detail?id=2561461507","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561461507?lang=en_us&edition=fundamental","pubTime":"2025-08-21 19:00","pubTimestamp":1755774001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nTUA7K30HT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIND"],"gpt_icon":0},{"id":"2561048289","title":"BRIEF-Vyome Enters Amendment No. 1 To Equity Distribution Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2561048289","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561048289?lang=en_us&edition=fundamental","pubTime":"2025-08-21 05:27","pubTimestamp":1755725221,"startTime":"0","endTime":"0","summary":"BRIEF-Vyome Enters Amendment No. 1 To Equity Distribution Agreement Aug 20  - Vyome Holdings Inc HIND.O:VYOME HOLDINGS INC - ENTERS AMENDMENT NO. 1 TO EQUITY DISTRIBUTION AGREEMENT - SEC FILINGVYOME HOLDINGS INC - AMENDMENT INCREASES OFFERING TO $12 MILLION - SEC FILINGSource text: [ID:n0001213900-25-079045]Further company coverage: HIND.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nFWN3UC0VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND"],"gpt_icon":0},{"id":"2561484040","title":"Vyome Holdings Inc - Amendment Increases Offering to $12 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2561484040","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561484040?lang=en_us&edition=fundamental","pubTime":"2025-08-21 05:24","pubTimestamp":1755725083,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nFWN3UC0VQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIND"],"gpt_icon":0},{"id":"2561484024","title":"Vyome Holdings Inc. Announces Change in Independent Auditor, Appoints Kreit & Chiu CPA LLP","url":"https://stock-news.laohu8.com/highlight/detail?id=2561484024","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561484024?lang=en_us&edition=fundamental","pubTime":"2025-08-21 05:24","pubTimestamp":1755725045,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc., formerly known as ReShape Lifesciences Inc., announced a change in its independent registered public accounting firm. On August 18, 2025, the company dismissed Haskell & White LLP and appointed Kreit & Chiu CPA LLP as its new auditor for the fiscal year ending December 31, 2025. This decision, approved by both the company's Audit Committee and Board of Directors, comes in the wake of material weaknesses identified in the internal control over financial reporting as of December 31, 2024. Despite these challenges, no disagreements on accounting principles or practices were cited with the outgoing firm. The transition aims to bolster the company's financial oversight and reporting capabilities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inves","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL3HzCmJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND"],"gpt_icon":0},{"id":"2560110688","title":"Vyome Holdings Inc. Completes Merger with Vyome Therapeutics, Renames Itself Following the Transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2560110688","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560110688?lang=en_us&edition=fundamental","pubTime":"2025-08-20 05:30","pubTimestamp":1755639018,"startTime":"0","endTime":"0","summary":"Vyome Holdings, Inc. has completed a merger with Vyome Therapeutics, Inc., finalizing a transaction initially announced on July 8, 2024. As per the merger agreement, Raider Lifesciences Inc., a wholly owned subsidiary of Vyome Holdings, merged with Vyome Therapeutics, with Vyome Therapeutics continuing as a subsidiary. Consequently, ReShape Lifesciences Inc. has been renamed Vyome Holdings, Inc. The merger involved the conversion of Vyome's common and preferred stock into shares of Vyome Holdings, with certain Indian stockholders subject to put-call option agreements. Additionally, Vyome's equity awards were converted into equivalent rights in Vyome Holdings. Prior to the merger's completion, an Amended and Restated Certificate of Designation to Series C Convertible Preferred Stock was filed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nNDL5Bpfbl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND"],"gpt_icon":0},{"id":"2560187818","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2560187818","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560187818?lang=en_us&edition=fundamental","pubTime":"2025-08-19 01:50","pubTimestamp":1755539409,"startTime":"0","endTime":"0","summary":"Vyome  said its board will conduct a review of alternatives for Livechain, an over-the-counter-listed company in which it holds a 70% stake.Vyome's stock fell 27% as intraday volume topped 185,700 shares, versus the daily average of almost 887,000.Empery Digital  shares slumped 22% after the company secured a $25 million credit facility for stock buybacks.Volume topped 1.85 million, versus the daily average of almost 635,000.SRx Health Solutions  signed a nonbinding agreement to acquire all assets of Royal Uranium, a uranium royalty firm with interests in Canada, Colombia, Argentina and Namibia.The shares dropped 23% as volume topped 15.3 million, versus the daily average of almost 11.5 million.Price: 10.20, Change: -3.80, Percent Change: -27.14","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4091","HIND","EMPD","BK4128","BK4212","SRXH"],"gpt_icon":0},{"id":"2560900924","title":"Vyome to Conduct Strategic Review of Livechain; Shares Down Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2560900924","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560900924?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:51","pubTimestamp":1755521515,"startTime":"0","endTime":"0","summary":"Vyome  said Monday its board will conduct a full review of strategic alternatives for Livechain, an over-the-counter-listed company in which it is the controlling shareholder with a 70% stake.Vyome Chairman Krishna Gupta said the board plans to spend the next month weighing costs and benefits of its options, \"which could include launching a new business, forming a crypto treasury, merging with an existing business, or an outright sale.\"Shares were down more than 11% in recent premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HIND"],"gpt_icon":0},{"id":"2560907437","title":"Vyome Announces Strategic Review of Livechain (Otcid: Lich)","url":"https://stock-news.laohu8.com/highlight/detail?id=2560907437","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560907437?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:30","pubTimestamp":1755520200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nTUA2VGWY2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HIND"],"gpt_icon":0},{"id":"2560907435","title":"Vyome Holdings Inc - Board to Review Options for Livechain, Including Sale or Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2560907435","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560907435?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:30","pubTimestamp":1755520200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nTUA2VGWY2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LICH","BK4023","HIND"],"gpt_icon":0},{"id":"2559696042","title":"ReShape Lifesciences Inc. Merges with Vyome, Now Trading as Vyome Holdings, Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2559696042","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559696042?lang=en_us&edition=fundamental","pubTime":"2025-08-15 07:19","pubTimestamp":1755213557,"startTime":"0","endTime":"0","summary":"Vyome Therapeutics, Inc. has announced a merger with ReShape Lifesciences Inc., resulting in the combined entity now operating as Vyome Holdings, Inc. under the trading symbol \"HIND\" on Nasdaq.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ReShape Lifesciences Inc. published the original content used to generate this news brief via Business Wire  on August 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL7YVkc6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","RSLS","HIND"],"gpt_icon":0},{"id":"2559103960","title":"Vyome Closes Merger Transaction, Will Trade on Nasdaq as Hind Tomorrow","url":"https://stock-news.laohu8.com/highlight/detail?id=2559103960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559103960?lang=en_us&edition=fundamental","pubTime":"2025-08-15 07:19","pubTimestamp":1755213540,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nTUA1VYY0M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","HIND","RSLS"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}]}}